VH1322: Section on Nicotine and Tobacco Prevention and Treatment Program

New Diseases and Tobacco’s Impact on Our Nation’s Public Health

Sunday, October 10, 2021

9:00 AM – 11:00 AM CDT

CME: 1.75

Session Type: Section/Council Program

Topic(s): Smoking & Tobacco

Sponsor(s): Section on Nicotine and Tobacco Prevention and Treatment

View full agenda here

Rx (Pharmacology): 1.75 Rx CS (Controlled Substance): 1.75

This program will focus on tobacco’s role in two major health crises: E-cigarette or Vaping Use-Associated Lung Injury (EVALI) and COVID-19 infection. An overview of legislative changes regarding tobacco and opportunities to mitigate such public health disasters will be presented. Issues of equity and inclusion related to tobacco use and exposure will be highlighted.

Virtual Faculty(s)

Valerie Gribben, MD, FAAP

Assistant Professor of Pediatrics
University of California San Francisco (UCSF)
Maria Rahmandar, MD, FAAP

Medical Director, Substance Use & Prevention Program
Lurie Children's Hospital of Chicago
Chicago, Illinois, United States

Slides
Susanne E. Tanski, MD, MPH, FAAP

Associate Professor, Pediatrics
Geisel School of Medicine at Dartmouth
Lebanon, New Hampshire, United States

Slides

Moderator(s)

Rachel Boykan, MD, FAAP

Hospitalist Physician, Clinical Professor of Pediatrics
Stony Brook University Hospital
Stony Brook, New York, United States
Susan C. Walley, MD, NCTTP, FAAP

Division Chief, Hospital Medicine
Children's National Hospital
Washington , District of Columbia, United States